Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.00 (0.00%)
Bid:
1.55
Ask:
1.85
Spread: 0.30 (19.355%)
Market Cap: £264.88k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Adjournment to the GM - Replacement

19 Nov 2021 11:25

RNS Number : 9835S
Iconic Labs PLC
19 November 2021
 

 

For immediate release

The following amendment has been made to the Adjournment to the GM announcement released on 18 November 2021 at 16:00 under RNS number 8773S.

The date of the further adjourned General Meeting has been amended to 23 November 2021.

All other details remain unchanged. 

ICONIC LABC PLC - IN ADMINISTRATION

The Joint Administrators provide the following update on the administration and the adjournment of General Meeting:

General Meeting

The General Meeting ("GM") which had been convened for 2.00pm on Tuesday 15 June 2021 and which was adjourned until Tuesday 17 November 2021 has been further adjourned to 2.00 p.m. on Tuesday, 23 November 2021 to be held at the same place as the GM was convened, namely the offices of KWM Europe LLP, being the 9th Floor, 24 Monument Street, London EC3R 8AJ or such other place as is notified to shareholders.

 

Proxies that have been submitted for the GM will remain valid for the adjourned GM and you do not need to submit a new proxy unless you wish to change how your proxy should vote. However, you may continue to submit a proxy form for the GM up to 2.00pm on Friday 19 November2021. Proxy forms must be submitted in accordance with the instructions set out in the notice of meeting dated 20 May 2021.

 

Progress of the Administration

CVA Proposals

In accordance with their Report & Proposals, the Joint Administrators have prepared Draft CVA Proposals which were circulated to the Board, Arch Capital Partners LLP ("Arch"), Greencastle Media and EHGOSF on 30 September 2021.

The Joint Administrators understand that negotiations are ongoing between the Board, EHGOSF and Arch the Secured Creditor. For a viable CVA proposal to be put to creditors and members, new funding will be required, or some other arrangement made available, to enable the Company to make settlement proposals to creditors. A CVA cannot bind Secured Creditors to the extent that they are secured. Therefore, a CVA will only be viable if the disputes (or a means for resolving them) between the Company, EHGOSF and Arch can be agreed.

 

It is hoped that the negotiations will be finalised shortly to enable the CVA Proposals to be finalised and circulated to creditors and shareholders, who will be entitled to vote at meetings called for that purpose.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGUKORRAWUAAAA
Date   Source Headline
2nd Jun 20265:18 pmRNSConversion of Notes and Allotment of Shares
29th May 20267:00 amRNSTotal Voting Rights
29th Apr 202612:58 pmRNSConversion of Notes and Allotment of Shares
31st Mar 20267:00 amRNSInterim Results
27th Feb 202610:23 amRNSTotal Voting Rights
23rd Feb 20267:00 amRNSConversion of Notes and Allotment of Shares
31st Dec 202511:37 amRNSResult of AGM
8th Dec 20252:16 pmRNSNotice of AGM
23rd Oct 20252:30 pmRNSFull Year Results
12th Aug 20252:04 pmRNSUpdate on Compliance with UK Listing Rules
30th Jun 20253:27 pmRNSHolding(s) in Company
30th Jun 20253:25 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSTotal Voting Rights
9th Jun 20254:28 pmRNSConversion of Notes and Allotment of Shares
6th Jun 20259:48 amRNSConversion of Notes and Allotment of Shares
3rd Jun 20252:54 pmRNSConversion of Notes and Allotment of Shares
30th May 20254:00 pmRNSConversion of Notes and Allotment of Shares
28th May 20255:24 pmRNSConversion of Notes and Allotment of Shares
28th May 20254:54 pmRNSHolding(s) in Company
28th May 20254:52 pmRNSHolding(s) in Company
28th May 20254:50 pmRNSHolding(s) in Company
28th May 20254:48 pmRNSHolding(s) in Company
20th May 20257:30 amRNSRestoration Iconic Labs Plc
20th May 20257:00 amRNSRestoration of Trading and Funding Update
15th May 20254:18 pmRNSResult of AGM
24th Apr 20255:16 pmRNSNotice of AGM
31st Mar 20256:41 pmRNSInterim Results
31st Mar 20255:26 pmRNSRevised Results for the Year ended 30 June 2024
13th Feb 20255:55 pmRNSTransaction Terminated
7th Feb 20252:52 pmRNSNotification of Major Holdings
31st Oct 20243:57 pmRNSFull Year Results for the Year ended 30 June 2024
9th Sep 20247:00 amRNSWaiver of Event of Default
10th Jul 20244:22 pmRNSBoard Changes
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities
30th Nov 20237:00 amRNSTotal Voting Rights
17th Nov 202311:32 amRNSConversion of Securities
13th Nov 20238:40 amRNSConversion of Securities
2nd Nov 202310:35 amRNSConversion of Securities
31st Oct 20239:29 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSFull Year Results for the Year ended 30 June 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.